Market News & Trends
BASF & Bend Research Sign Bioavailability Agreement
BASF SE and Bend Research Inc. have signed an agreement to jointly evaluate and develop novel excipients to enhance the solubility and bioavailability of…
BioCellChallenge Launches First Universal Delivery System for Transporting Antibodies Into Live Cells
BioCellChallenge SAS recently announced the launch of a new delivery system, ImmunoCellin, which is designed to transport antibodies into live cells even in the presence…
Capsugel Launches New Dosage Form Solutions Business Unit
Capsugel recently announced the launch of its Dosage Form Solutions (DFS) business unit to address growing customer demand for innovative product development and commercial…
Dow Chemical & Cambrex Collaborate to Manufacture Drug Solubility Solution
Cambrex and The Dow Chemical Company recently executed an agreement for Cambrex to contract manufacture Dow Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) for Drug Solubility…
2/20/2013
Argos Therapeutics Announces Updated Phase II Data Argos Therapeutics Inc. recently announced updated results from its Phase II study of AGS-003, its most advanced product…
93% Shares of OctoPlus Acquired
Dr Reddy's Laboratories (DRL), which is in the process of acquiring Netherlands-based speciality pharmaceutical company OctoPlus NV for about 27.4 million euro, has so…
Argos Therapeutics Announces Updated Phase II Data
Argos Therapeutics Inc. recently announced updated results from its Phase II study of AGS-003, its most advanced product candidate for the treatment of metastatic…
Biosimilars Market Expected to Soar
Top representatives from the healthcare industry were confirmed to attend the 2nd Biosimilars Congregation which took place in London on February 19 and 20.…
Nexavar Continues to Dominate Advanced Liver Cancer Therapy
Hepatocellular carcinoma (HCC), the most common form of liver cancer, carries a deadly reputation, and patients face shrinking hopes of new treatment options as…
Opioid Drug Abuse Will be Tackled Through New Delivery Methods
The opioid pain management market will continue to evolve throughout the coming years with new products and post-marketing studies that aim to reduce the…
Third Rock Ventures Launches Cancer Immunotherapeutics Company With $47 Million
Third Rock Ventures, LLC recently announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is…
2/13/2013
Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential therapeutic approaches available to treat…
Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders
The range of potential therapeutic approaches available to treat cancer is expected to expand rapidly during the next decade. Current diagnostic technologies focus on…
Lycera Expands Partnership With Merck; Potential $600-Million Deal
Lycera Corp. recently announced a collaboration agreement with Merck to discover, develop, and commercialize small-molecule therapies directed to selected novel targets being investigated for…
Novozymes Biopharma Announces Agreement With EpiVax
Novozymes Biopharma recently announced a collaborative research agreement with Rhode Island-based biotech company, EpiVax, Inc. to help further the development of a potential paradigm-shifting…
Perrigo Buys Company for $283 Million
Perrigo Company recently announced it has signed a definitive merger agreement and has completed the acquisition of Leeds, U.K.-based Rosemont Pharmaceuticals Ltd. for approximately…
Second Expansion Underway for Rexam Healthcare
Four years after its first extension, Rexam is again expanding its La Verpillière site (near Lyon) to create a building including approx. 2400 m2…
Xenon Receives Major Milestone for Marketing Approval
Xenon recently announced it has received a milestone payment from uniQure BV for the European Commission marketing approval of Glybera, a novel gene therapy…
2/6/2013
Foresite Capital Closes $100 Million Fund for Late-Stage Biotechs Biotech venture capital isn't what it used to be, but there's still money to invest in…
Bend Research Receives EU Certificate
Bend Research Inc. recently announced it has received certification of compliance with European Union (EU) Good Manufacturing Practice (GMP) regulations. This broad certification, which…
